S
SAB Biotherapeutics, Inc. (SABS)
NCM – Real vaqt narxi. Valyuta: USD
3.80
-0.07 (-1.81%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
3.81
+0.01 (0.34%)
Bozordan keyin: Jun 26, 2026, 7:14 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
3.80
-0.07 (-1.81%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
3.81
+0.01 (0.34%)
Bozordan keyin: Jun 26, 2026, 7:14 PM EDT
This stock has a consensus price target of $10.54 based on the ratings of 14 analysts. The high is $15.00 and the low is $6.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 6 | $ 10.54 | $ 15 |
| O’zgarish | 63.93% | 187.98% | 309.84% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-06-15 | 215.79% | Leerink Partners | $7 → $12 | Maintains | Outperform |
| 2026-06-15 | 163.16% | HC Wainwright & Co. | $10 → $10 | Reiterates | Buy |
| 2026-05-22 | 189.47% | Citigroup | $11 | Initiates Coverage On | Buy |
| 2026-05-20 | 189.47% | Jefferies | $11 | Initiates Coverage On | Buy |
| 2026-05-12 | 163.16% | HC Wainwright & Co. | $7 → $10 | Maintains | Buy |